Melinta Therapeutics Inc (MLNT)

$7.25 $-0.2 (-2.68%)

  • Last Price:
    $7.25
  • Previous Close:
    $7.45
  • Change:
    $-0.20 (-2.68%)
  • Open:
    $7.35
  • Volume:
    24,280
  • Day's Range:
    $7.25 - $7.55
  • Dividend Yield:
    0%
  • 52-week Range:
    $24.25 - $6.50
  • P-E:
    0
  • EPS:
    $-21.86

Melinta Therapeutics Inc is a commercial-stage biopharmaceutical company. It is developing antibiotic, Baxdela (delafloxacin), for the treatment of adults with serious skin infections known as acute bacterial skin and skin structure infections.

It seems we can’t find what you’re looking for. Perhaps searching can help.